Literature DB >> 15343351

Can oral sucrose reduce the pain and distress associated with screening for retinopathy of prematurity?

Joanna Grabska1, Peter Walden, Trudy Lerer, Christopher Kelly, Naveed Hussain, Terese Donovan, Victor Herson.   

Abstract

OBJECTIVE: Infants undergoing eye exams to screen for retinopathy of prematurity (ROP) demonstrate physiologic and behavioral manifestations of pain and distress. Oral sucrose has analgesic properties that might reduce these effects. AIM: To determine the efficacy of oral sucrose in reducing the pain/distress of eye exams for ROP.
METHODS: A total of 32 infants about to undergo ROP screening exams received either oral sucrose [S] (N=16) or sterile water [C] (N=16) in a randomized, prospective and blinded fashion. Outcome measures included HR, RR, O(2) saturation, BP, pain (premature infant pain profile) and percent of time spent crying during the eye exam.
RESULTS: The groups were similar in GA (weeks) (28+/-1.6), BW (kg) (1.04+/-0.26), postnatal age (days) 50.8+/-20.3, and study weight (kg) 1.88+/-0.40). Both groups demonstrated significant increases in HR, BP, and pain score in response to the exam. Infants in both groups spent the majority of time actively crying during the exam ([S] 53+/-35% vs [C] 63+/-31%. Infants receiving [S] showed a small but significant drop in O(2) saturation. No significant differences were seen between groups in physiologic or behavioral responses to the eye exam.
CONCLUSION: Oral [S] was not effective in reducing pain/distress from the ROP screening exam. Alternative strategies should be considered to achieve adequate pain relief.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15343351     DOI: 10.1038/sj.jp.7211199

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  19 in total

1.  N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity.

Authors:  Christoph Bührer; Ömer Erdeve; Anton van Kaam; Angelika Berger; Evelyn Lechner; Benjamin Bar-Oz; Karel Allegaert; Tom Stiris; İstemi Han Çelik; Janet Berrington
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

2.  Reducing discomfort of eye drops prior to retinal examination in the neonatal intensive care unit.

Authors:  Dan Ni Wang; Kyla Lavery; Stacey Dalgleish; Alexandra Howlett; Vivian E Hill; Stephanie A Dotchin
Journal:  J Perinatol       Date:  2020-10-15       Impact factor: 2.521

3.  Oral Dextrose for Pain Management during Laser Treatment of Retinopathy of Prematurity under Topical Anesthesia.

Authors:  Manisha Kataria; Subina Narang; Deepak Chawla; Sunandan Sood; Parul Chawla Gupta
Journal:  Indian J Pediatr       Date:  2015-02-17       Impact factor: 1.967

4.  Reducing pain from heel lances in neonates following education on oral sucrose.

Authors:  Mark Shen; Gladys El-Chaar
Journal:  Int J Clin Pharm       Date:  2015-03-06

5.  Comparison of strategies for grading retinal images of premature infants for referral warranted retinopathy of prematurity.

Authors:  David L Rogers; Don L Bremer; Rae R Fellows; Agnieshka Baumritter; Ebenezer Daniel; Max Pastilli; Gui-Shang Ying; Graham E Quinn
Journal:  J AAPOS       Date:  2017-03-20       Impact factor: 1.220

6.  Retinal and Optic Nerve Hemorrhages in the Newborn Infant: One-Year Results of the Newborn Eye Screen Test Study.

Authors:  Natalia F Callaway; Cassie A Ludwig; Mark S Blumenkranz; Jennifer Michelle Jones; Douglas R Fredrick; Darius M Moshfeghi
Journal:  Ophthalmology       Date:  2016-02-11       Impact factor: 12.079

7.  Physiologic effects of retinopathy of prematurity screening examinations.

Authors:  Anita J Mitchell; Angela Green; Debra A Jeffs; Paula K Roberson
Journal:  Adv Neonatal Care       Date:  2011-08       Impact factor: 1.968

Review 8.  Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges.

Authors:  Grace M Richter; Steven L Williams; Justin Starren; John T Flynn; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2009-08-08       Impact factor: 6.048

9.  Low dose fentanyl infusion versus 24% oral sucrose for pain management during laser treatment for retinopathy of prematurity-an open label randomized clinical trial.

Authors:  Amanpreet Sethi; M Jeeva Sankar; Srikanth Kulkarni; Anu Thukral; Parijat Chandra; Ramesh Agarwal
Journal:  Eur J Pediatr       Date:  2019-11-15       Impact factor: 3.183

10.  Sucrose and non-nutritive sucking for the relief of pain in screening for retinopathy of prematurity: a randomised controlled trial.

Authors:  E M Boyle; Y Freer; Z Khan-Orakzai; M Watkinson; E Wright; J R Ainsworth; N McIntosh
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01-20       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.